(Q40320137)

19 September 2017

title

Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors (English)

1 reference

19 September 2017

15

Young Il Yeom

1 reference

19 September 2017

Mi Jung Lim

1

1 reference

19 September 2017

Sang-Hyun Min

2

1 reference

19 September 2017

Jae-Jung Lee

3

1 reference

19 September 2017

Il Chul Kim

4

1 reference

19 September 2017

Ji Tae Kim

5

1 reference

19 September 2017

Dong Chul Lee

6

1 reference

19 September 2017

Nam-Soon Kim

7

1 reference

19 September 2017

Sangkyun Jeong

8

1 reference

19 September 2017

Mi Na Kim

9

1 reference

19 September 2017

Kwang Dong Kim

10

1 reference

19 September 2017

Jong-Seok Lim

11

1 reference

19 September 2017

Sang Bae Han

12

1 reference

19 September 2017

Hwan Mook Kim

13

1 reference

19 September 2017

Dae Seog Heo

14

1 reference

19 September 2017

publication date

3 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

899-909

1 reference

Human papillomaviruses and their role in cervical cancer

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Rapid progression of primary vaginal squamous cell carcinoma in a young HIV-infected woman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Simian virus 40 infection in humans and association with human diseases: results and hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Sibling rivalry in the E2F family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

E2F and cell cycle control: a double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Role of T antigen interactions with p53 in tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Adenovirus and cell cycle control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

The role of TP53 in Cervical carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Control of E2F activity by p21Waf1/Cip1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Functional interaction between DP-1 and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Inactivation of p53 gene in human and murine osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Ras induces elevation of E2F-1 mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Rb function in cell-cycle regulation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Analysis of the cycling and noncycling cell population of human solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Role of the retinoblastoma protein in the pathogenesis of human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Transcriptional regulation by the Sp family proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

The interactions of transcription factors and their adaptors, coactivators and accessory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Cancer gene therapy: fringe or cutting edge?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Transcriptional Control Signals of a Eukaryotic Protein-Coding Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Characterization and quality control of recombinant adenovirus vectors for gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

Human papillomavirus infection in the malignant and premalignant head and neck epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.11.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2005.11.023

1 reference

19 September 2017

1 reference